Twist Bioscience Corporation
TWST
$55.95
-$0.26-0.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 409.48M | 391.56M | 376.57M | 362.27M | 347.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 409.48M | 391.56M | 376.57M | 362.27M | 347.68M |
| Cost of Revenue | 196.25M | 189.42M | 185.57M | 183.88M | 185.31M |
| Gross Profit | 213.23M | 202.13M | 191.00M | 178.40M | 162.37M |
| SG&A Expenses | 272.95M | 260.54M | 246.98M | 236.36M | 229.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 541.09M | 526.07M | 512.83M | 504.64M | 503.92M |
| Operating Income | -131.61M | -134.51M | -136.26M | -142.37M | -156.24M |
| Income Before Tax | -80.53M | -75.71M | -76.95M | -84.82M | -190.78M |
| Income Tax Expenses | 744.00K | 876.00K | 720.00K | 367.00K | 367.00K |
| Earnings from Continuing Operations | -81.28 | -76.58 | -77.67 | -85.19 | -191.15 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.28M | -76.58M | -77.67M | -85.19M | -191.15M |
| EBIT | -131.61M | -134.51M | -136.26M | -142.37M | -156.24M |
| EBITDA | -110.34M | -113.25M | -114.81M | -119.96M | -131.60M |
| EPS Basic | -1.32 | -1.27 | -1.30 | -1.45 | -3.26 |
| Normalized Basic EPS | -1.25 | -1.29 | -1.32 | -1.41 | -1.55 |
| EPS Diluted | -1.33 | -1.28 | -1.31 | -1.46 | -3.26 |
| Normalized Diluted EPS | -1.25 | -1.29 | -1.31 | -1.40 | -1.55 |
| Average Basic Shares Outstanding | 243.20M | 241.15M | 239.23M | 237.36M | 235.51M |
| Average Diluted Shares Outstanding | 244.37M | 242.32M | 240.40M | 238.53M | 235.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |